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↑What is “already known” in this topic: 
Surveys of opinion and practice looking at emergency 
management has shown that clinicians’ opinions on inter-
ventions do not necessarily reflect what really happens in 
practice.   
→What this article adds: 
This first Middle Eastern survey of psychiatric emergency 
room practice illustrates how, like elsewhere, what clini-
cians wish to happen and what actually occurs in clinical 
front-line practice is somewhat different. 
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Abstract 
    Background: Violent patients constitute 10% of all psychiatric admissions. Treatment options and clinical practice interventions 
vary across the globe and no survey of practice in a Middle Eastern setting exists. Surveying treatments in Lebanon will show treat-
ment interventions used in this part of the world and, most importantly, provide the treatment options that could potentially be used for 
clinical trials pertaining to emergency psychiatry. 
   Methods: A survey of clinicians’ opinions and practice was conducted between July and August 2017 at the largest psychiatric hos-
pital in Lebanon. 
   Results: Five of seven experienced psychiatrists provided opinions when interviewed of their preferred intervention when dealing 
with an emergency psychiatric episode. Whilst this varied in detail, there was a consistent view that there should first be verbal control, 
then use of medications, and finally physical restrain of the patient. A total of 39 emergency episodes (28 people) occurred in the one 
month (64% men in their 30s). Bipolar disorder was the most frequent single diagnosis behind the aggression (n=16, 41%; 12 people 
43%) but the combined schizophrenia-like illnesses underlay 18 of the 39 episodes (46%; 13/28 people 46%). In clinical life, we found 
evidence of high family involvement, but little attempts made at initial verbal control in the hospital. All 39 episodes involved admin-
istration of pharmacological interventions. Medications were used in 29 of cases (74%) and non-medication interventions used in the 
remaining 10/39 (26%). 
   Conclusion: This survey provides some evidence that clinicians’ preferences may not fully reflect clinical practice but also that ex-
perienced clinicians are using several clearly effective techniques to manage these very difficult situations. However, as for other parts 
of the world, treatment in Lebanon has limited or no underpinning by evidence from well-designed, conducted and reported evaluative 
studies.  
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Introduction 
Aggressive and violent behaviour is a common phe-
nomenon seen in the psychiatric setting with an average of 
10% of psychiatric patients prone to a violent episode 
requiring rapid tranquilization (1). Guidelines recommend 
aggressive patients to be ‘verbally tranquilised’ in order 
for the attending physician to accurately and safely per-
form a diagnostic history and physical examination (2). 
Aggressive patients may make this process difficult and 
potentially impossible and doctors and nurses face a di-
lemma and are required to work with limited knowledge. 
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Since the psychiatric team has a responsibility of ensuring 
the safety of everyone, rapid and safe tranquilisation may 
become an unavoidable option (3). 
Medication, restriction within a safe environment and 
physical restraints are available options to calm an agitat-
ed patient. Medication can be given orally (including aer-
osol or swiftly dispersible tablet), intravenously (IV) or 
intramuscularly (IM). Often oral and IV medications are 
impossible when the patient is lashing out aggressively. 
Restriction or restraints may include the use of a seclusion 
room or safe space, physical restraints by binding the pa-
tient safely to a bed, straitjackets, or holding the person 
down with or without physical restraints. All options are 
unpleasant and infringe freedom; all have advantages and 
disadvantages (4). For example, IV medication may work 
faster when tranquilising an agitated patient but may also 
lead to cardiac and respiratory problems – not to mention 
extreme difficulties of delivering the treatment intrave-
nously into an aggressive patient (5). IM medications are 
easier to administer making them more efficient in terms 
of implementation but the time to onset of effect is longer 
and less predictable than for IV (6). Physical restraints 
prevent aggressive patients from physically assaulting 
staff or themselves. Their use may have the advantage 
allowing safer delivery of IV or IM medication and, per-
haps lower and less frequent doses of the latter (7). An 
additional advantage is that they allow control of difficult 
behaviour in a situation where staff numbers are not high 
and provision of high staff attendance to one patient will 
result in relative neglect of others. The disadvantages, 
however, are considerable, with the overt restriction of 
people’s freedom. Restraining a person is associated with 
the danger of death via asphyxiation, trauma or cardiac 
event (8). All methods are coercive and have potential to 
be abused. Using the least restrictive option is desirable, 
but this differs depending on setting, treatment availabil-
ity, clinicians’ preference and skill set, and current custom 
of practice.  
Evidence underpinning the treatments is limited. Ran-
domised trials in this area are difficult and few treatment 
options are supported by large unbiased trials with clear 
outcomes of clinical value (Table 1. Reviews of clinical 
trials on agitation and interventions) (9-25). Understanda-
bly, guidelines differ in their recommendations in line 
with the limited evidence and local clinical preferences.  
As preparatory work for a local randomised trial, a sur-
vey of clinicians’ treatment preference and practice in 
Lebanon was undertaken mirroring work done in Brazil 
(26). The aim of this study was to survey the opinion of 
attending clinicians on how acute aggression should be 
managed and to compare it with actual clinical practice. 
The major reason this survey is titled ‘survey of treatment 
in Lebanon’ is mainly due to the fact that the Psychiatric 
Hospital of the Cross is the largest and only major psychi-
atric public hospital exists in the country; therefore though 
limited, it reflects the only available treatment options that 
could potentially be surveyed.  
 
Methods 
The study excluded children (<18) and the elderly 
(>65). Eligible participants were selected on the basis of 
being admitted to the psychiatric hospital and having an 
agitated episode that required rapid tranquilisation.  
 
Site 
The survey was carried out between July and August 
2017 in the Psychiatric Hospital of the Cross (PHC), the 
largest psychiatric hospital in Lebanon.  
 
Ethical aspect 
These surveys were carried out after gaining ethical ap-
proval from the University of Nottingham specifically the 
Division of Psychiatry and Applied Psychology in the 
School of Medicine and is overseen by the Faculty of 
Medicine & Health Sciences’ Research Ethics Committee 
(Reference number 242). The application was in line with 
the University of Nottingham’s Code of Research Conduct 
and Research Ethics (2016). The Psychiatric Hospital of 
the Cross Ethics and Research Committee, in compliance 
with the Hospital’s Regulatory Research Protocol also 
approved the study design based on the facts that it was an 
observational study that respected participants’ autonomy 
and confidentiality and induced minimal harm to 
them. Written consents were obtained from clinicians and 
patients. Patients with no proper mental status to give con-
sent were under care of the attending physician responsi-
Table 1. Reviews of clinical trials on agitation and interventions 
Completed and maintained reviews 
'As required' medication regimens for seriously mentally ill people in hospital (9) 
Benzodiazepines for psychosis-induced aggression or agitation (10) 
Chlorpromazine for psychosis-induced aggression or agitation (11) 
Clotiapine for acute psychotic illnesses (12) 
Containment strategies for people with serious mental illness (13) 
De-escalation techniques for psychosis-induced aggression (14) 
Droperidol for acute psychosis (15) 
Haloperidol for long-term aggression in psychosis (16) 
Haloperidol for psychosis-induced aggression or agitation (rapid tranquillisation) (17) 
Haloperidol plus promethazine for psychosis-induced aggression (18) 
Olanzapine IM or velotab for acutely disturbed/agitated people with suspected serious mental illnesses (19) 
Seclusion and restraint for serious mental illnesses (20) 
Zuclopenthixol acetate for acute schizophrenia and similar serious mental illnesses (21) 
Reviews in the process of being completed                                                                                                                                                            
Risperidone for psychosis-induced aggression or agitation (22) 
Loxapine inhaler for psychosis-induced aggression (23) 
Clozapine for people with schizophrenia and recurrent physical aggression (24) 
Quetiapine for psychosis-induced aggression or agitation (25) 
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ble for the patient. Patients were not given any experi-
mental drugs but rather the hospital’s routine practice in-
tervention during emergency situations.  
 
Forms 
Clinician’s opinion 
Form 1 had space to record clinicians’ opinions on 
which intervention techniques should be used when treat-
ing an agitated patient. There was no limit on intervention 
options. The simple form also could be used to gather 
information on the duration of clinicians’ mental health 
experience as well as current estimates of how often does 
he or she treats agitated patients (See Form 1 in Appen-
dix).  
 
Clinical practice 
Form 2 was used to record practice for every episode of 
emergency management within the hospital, within the 
time period; one form for each agitated episode. This form 
was also simple and quick to complete. A unique identifi-
er was assigned to every patient, as were details of the 
ward and whether the patient thought to be new or some-
one already known to services. A suspected cause for the 
aggression was noted, along with the suggested diagnosis. 
Age and sex were included. The form held space for a 
‘Presentation’ variable encouraging recording of how the 
person arrived – via family, authorities, friends, by them-
selves or ‘others’. The form also had space for recording 
of whether the patient was restrained or/and received med-
ication before admission. Finally, the form left space to 
list all treatments administered to the person (See Form 2 
in Appendix). 
 
Procedures 
Clinician’s opinion 
Concerning the clinicians’ form, five out of seven were 
completed and returned immediately via a face-to-face 
interview. Of the remaining two psychiatrists, one was 
unwilling to fill out the form citing that he spends too 
much time outside Lebanon and felt his input would be 
unrepresentative and the other was unreachable during the 
one month study period.  
 
Emergency episode practice 
Data were collected in the three main hospital wards 
throughout the study period. When patients are admitted – 
either new or recurring - they must go through a 
centralised administrative system. Staff were informed 
regarding the study and recorded agitated episodes even 
when the researcher was not present, thus alerting him to 
the need for data acquisition. No episode was missed 
within the study period. 
The researcher filled out the form by obtaining patients’ 
case files and re-recording the treatments given during and 
after agitated episodes. If the patient continued having 
agitated episodes during the day, one form covered the 
period until the situation was tranquil. If the patient had 
one agitated episode and became tranquil but if it seemed 
as a new agitated episode occurred, this was considered a 
separate episode with one form per episode. After every 
form was completed, a unique ID was given for each indi-
vidual to allow traceability but to guarantee anonymity. 
  
Results 
Clinicians  
A total of seven psychiatrists were given the survey re-
questing their opinion of how aggression should be man-
aged. Five completed the survey. All were selected on the 
basis of being employed in PHC. The five clinicians treat-
ed people with aggression daily (2), weekly (2) or month-
ly (1), worked across wards dealing with men or women 
and had a considerable depth of experience (see Table 2. 
Table 2. Data results of Clinicians' Opinions 
Psychiatrist Experience 
(years) 
Frequency 
of treating 
emergencies 
Intervention 
#1 #2 #3 #4 #5 #6 #7 
1 19 Daily * 
Verbal 
Intervention 
** 
Propose 
tranquilising 
tablet 
*** 
Propose IM 
treatment 
***  
HPL 
****  
Physical 
Restraint 
***, **** 
Physical 
Restraint,  
Chemical 
Restraint 
*** Zuclopen-
thixol 
2 7 Weekly ** 
Pharmacological 
Intervention 
**** Seclu-
sion Room 
**** 
Physical Re-
straint 
   
         
3 13 Daily * 
Rule out medical 
causes 
* Therapeu-
tic Interven-
tion 
*  
Refer to psy-
chotherapy 
* 
Assess 
risk of 
aggression 
*** 
HPL 
 
         
4 10 Weekly **  
Propose tran-
quilising tablet 
* 
Attain ap-
proval from 
parents 
***  
HPL 
   
         
5 30 Monthly * 
Give time for 
patient to calm 
down 
*** 
Olanzapine 
(oral form) 
    
HPL: Haloperidol + Promethazine + Chlorpromazine, IM: Intramuscular Injection,  Codes: * Non-physical, ** Oral Medication, *** IM Medication, ****  Restrictive 
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Data results of Clinicians' Opinions).  
Clinicians’ opinion of what interventions should take place 
Psychiatrists suggested three broad categories of inter-
vention - non-physical, medication and restrictive. All 
psychiatrists’ first line of intervention were non-physical 
(non-pharmacological) preferring verbal intervention 
(talking down techniques). Thereafter, there was a drift to 
use oral medication followed by IM delivery choices. Cli-
nicians tended to not be too specific about which oral 
medication to choose. The two IM treatments mentioned 
were haloperidol and zuclopenthixol acetate (Table 2). 
 
Clinical practice 
Patients’ background and admission data 
A total of 28 patients (39 episodes) were included in the 
one month survey of practice (1.26 people/day required 
rapid tranquilisation). All were adults of Lebanese nation-
ality.  
Most patients were male, in their early 30s, and present-
ed with their families. In a few instances restraints were 
used before admission (7%) and people had already re-
ceived some sort of medical intervention (10%) such as 
being restraint or given medication by family, friends or 
self before being presented to the hospital (Table 3).  
The male-only wards experienced a little higher fre-
quency of agitated episodes but not crucially so (Table 4). 
Taken alone, bipolar disorder, was the most frequent sin-
gle diagnosis (n=12) but the collective schizophrenia-like 
illness (schizophrenia, schizoaffective disorder, delusional 
disorder, brief psychotic episode) totalled 13 of the 39 
episodes.   
 
Interventions used   
Table 5 includes the interventions used in the 39 emer-
gency episodes.  
 
Verbal 
Every clinician had suggested that verbal interventions 
should be the first line. The survey form encouraged re-
cording of both drug and non-drug approaches. However, 
in the entirety of the study, the verbal command was re-
ported as being used only once as a first line of treatment. 
 
Medications 
All 39 agitated episodes received a first line treatment, 
25 (64%) received a second line intervention, 14 (36%) a 
third, 8 (21%) a fourth, 7 (20%) a fifth and 1 (3%) six 
interventions. All drug interventions were given IM – in-
cluding clozapine which is available in this form in Leba-
non - when patients were agitated and requiring rapid 
tranquilisation. There was no evidence that an oral option 
was given or offered – contrary to the clinician’s opinion 
expressed in Table 2.  
Diazepam IM was the most commonly used first and 
second-line drug treatment (total =16). It is known for 
causing residual pain at the site of injection and being 
erratic in its absorption (27-28). The second most used 
first-line intervention was a mix of haloperidol, prometha-
zine, and chlorpromazine. This mixture, called “HPC” by 
the hospital is, according to hospital staff, the preferred 
‘SOS’ [true emergency] treatment. It was used a total of 
seven times as first line treatment but, over the whole 
survey, it was the most commonly employed rapid 
tranquilisation (n=18). The third most used was a 
haloperidol promethazine mix – four times as a first-line 
intervention.  
The remaining drugs were benzhexol (an anticholinergic 
drug used to offset acute movements caused by antipsy-
chotic drugs), or antipsychotics (chlorpromazine, clozap-
ine, haloperidol, olanzapine, promethazine, zuclopenthix-
ol) or benzodiazepines (diazepam, lorazepam) either used 
as a sole treatment or in combinations. 
 
Restrictive 
Although, from the reported preferences of clinicians, 
restraints were an available option, in reality, straitjackets 
were employed. Clinicians also had stated that restriction 
by use of restraints should be an option taken at least 
fourth after other measures. In reality, the strait jacket 
seems to have been used as first-line six times, and sec-
Table 3. Background of episode 
Sex Male Female   Total 
 25 (64%) 14 (36%)   39 (100%) 
Age Mode Mean Range   
 31 (n=6) 33 (SD 8.9) 18-58   
Presentation Families Authorities By themselves Other Total 
 26 (67%) 3 (8%) 4 (10%) 6 (15%) 39 (100%) 
Before admission      
 Restraints Yes No   Total 
 7 (18%) 32 (82%)   39 (100%) 
 Medication Yes No   Total 
 4 (10%) 35 (90%)   39 (100%) 
Table 4. Episode data 
Ward Male only 18 (46%) 
Male & Female 12 (31%) 
Female only 9   (23%) 
 Total 39 (100%) 
Day Sunday 1   (3%) 
Monday 12 (30%) 
Tuesday 9   (23%) 
Wednesday 6   (16%) 
Thursday 7   (18%) 
Friday 2   (5%) 
Saturday 2   (5%) 
 Total 39 (100%) 
Frequency Range 1-12/day 
Diagnosis Schizophrenia 10 (35%) 
Bipolar Disorder 12 (43%) 
Substance use 3   (10%) 
Schizoaffective Disorder 1   (4%) 
Brief Psychotic Disorder 1   (4%) 
Delusional Disorder 1   (4%) 
 Total 28 (100%) 
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ond-line two (Table 5). In totality, the strait jacket ranked 
third most used intervention – both non-drug and drug - in 
the entire survey. Seclusion does not seem to have been 
used despite being one option suggested by the survey of 
clinician’s opinion.  
 
Discussion 
Overall 
This was, however, the first study of its kind in Lebanon 
to survey treatment options of both clinicians’ opinions 
and practice in this difficult emergency situation. Out of 
necessity, it was small and short but its findings are not 
that different to other similar work. Few studies have un-
dertaken parallel surveys of clinician’s opinion alongside 
what happens to patients in their care and the survey of the 
doctors in Lebanon reported here was certainly limited in 
size. It did, however, suggest that desired practice is not 
really what happens on the front line – as was found by 
similar surveys (29-33). 
There is no international consensus pertaining to the 
most effective treatment. The National Institute for Health 
and Care Excellence (NICE) guidelines suggest using 
lorazepam only in situations where there are not any non-
psychotic behavioural disturbance (34).  Guidelines from 
the American Psychiatric Association (APA) (35) and 
from the Canadian Psychiatric Association (CPA) (36) 
both suggest using anti-psychotic drugs as first line treat-
ment. The APA guidelines encourage haloperidol or atyp-
ical antipsychotics while the CPA guidelines suggest us-
ing the second-generation antipsychotic drugs. Unlike the 
CPA and NICE guidelines, the guidelines from the Royal 
Australian and New Zealand College of Psychiatrists 
(RANZP) (37) recommend zuclopenthixol even in drug 
naïve patients mainly to avoid repeated injections. The 
results of this survey share similarities in terms of using 
benzodiazepines and anti-psychotics alike. While the 
NICE recommends lorazepam which is available and used 
in the Lebanese practice, it is not the leading benzodiaze-
pine option - which is diazepam. Lebanon shares more 
similarities with the APA, CPA, and RANZP that using 
antipsychotics as the emergency treatment intervention. 
However, although Lebanon’s haloperidol, promethazine 
and chlorpromazine combination is known to be used in 
other care settings (26), it is not seen in these major guide-
lines.  
As regards that clinical front line, the age, sex and likely 
diagnosis of people presenting in this situation seems 
broadly similar to what is known from other surveys (38-
40). The exception is the absence of people with the diag-
nosis of personality disorder. The latter is not a diagnosis 
that is routinely recorded in Lebanon so figures reported 
in Table 4 may be under-representative of this diagnosis. 
It is also possible that people who present at the hospital 
are, in effect, pre-screened by the families and community 
services to really be only those with functional mental 
illnesses.  
How the person arrived at the hospital gives a basic im-
pression of the prevalent care-culture in Lebanon. Largely 
people were accompanied by one or more family mem-
ber(s). Although a few did receive pre-admission medica-
tions (not listed) most presented without prescribed drugs. 
Seven people were placed in physical restraints before 
admission. When brought by police, handcuffs were used 
as a physical restraint, while a straitjacket was used if the 
patient was brought in by hospital staff.  
The results for the survey of practice yielded four main 
intervention options. For the non-pharmacological inter-
ventions, the straitjacket was used eight times (20%; 95% 
CI 11-36%). This survey did not have the details of its 
implementation, how long it was employed, the result of 
its use and if it caused adverse effects. Use of this ap-
proach has not been the study of much scientific enquiry 
and it is clearly a commonly used way of rendering the 
person safe in Lebanon.  
Nearly half of first line treatments were either diazepam 
or a haloperidol plus promethazine mix (with a proportion 
of the latter having additional chlorpromazine). When 
non-pharmacological approaches are removed this propor-
tion rises to 59%. The most common first line sole drug 
treatment for rapid tranquilisation in this survey was in-
tramuscular diazepam. This treatment is known to have 
erratic absorption and cause residual pain at the injection 
Table 5. Intervention order 
  First Second Third Fourth Fifth Sixth 
Non-drug interventions Verbal Command 1      
Strait jacket 6 2   1  
Drug interventions (all 
IM) 
Diazepam 8 5 2 1   
Haloperidol + Promethazine + Chlorpromazine  7 5 4 1 1  
Haloperidol + Promethazine +/- Benzhexol 4 4     
Chlorpromazine + Lorazepam 2      
Lorazepam 2 2 1    
Zuclopenthixol + Promethazine 2    1  
Chlorpromazine 1 3 3 2 1  
Chlorpromazine + Promethazine 1      
Diazepam + Lorazepam + Promethazine 1      
Haloperidol 1      
Haloperidol + Promethazine + Chlorpromazine + 
Lorazepam 
1      
Olanzapine 1      
Zuclopenthixol 1    1  
Promethazine  4 1 4 2 1 
Clozapine   1     
Benzhexol   3    
Total  39 25 14 8 7 1 
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site (27-28). The first line use of diazepam was similar to 
the UK survey of the early 1990s (41) but this now seems 
to have been eclipsed in the UK by lorazepam (42). The 
latter is not heat stable and necessitates the use of fridges 
but these are available in Lebanon. It could be that the use 
of diazepam is an issue of availability and familiarity. The 
haloperidol plus promethazine mix was used 11 times first 
line but in seven instances additional chlorpromazine was 
added. This triple mix was the hospital’s main ‘SOS’ 
treatment option for rapidly tranquilising agitated patients 
and here clinical practice does broadly concur with the 
opinion of the attending clinicians. This [likely potent] 
mix was also employed in Brazil (27).  
Forty per cent of drug treatments were given only once 
or twice first line. Various combinations of chlorproma-
zine, diazepam, haloperidol, lorazepam, olanzapine, pro-
methazine, and zuclopenthixol were used with no clear 
indication why these chosen as opposed to the diazepam 
or haloperidol/promethazine +/- chlorpromazine mix. This 
proportion of ‘various available variations’ is similar to 
that seen in other surveys and is likely to be the result of a 
combination of clinical judgment and clinical freedom.  
Although Lebanon favoured use of the haloperidol-
promethazine-chlorpromazine combination more than has 
been seen in other countries (Table 6) but use of these 
drugs in this way has been seen elsewhere (27). Perhaps 
what is most striking are the similarities between Lebanon 
and the rest of the world. Clinicians here, as elsewhere 
(30,39,43) recommend initial use of least restrictive op-
tions first, and then medications and finally restrictions on 
movements.  Also, clinicians’ choice in Lebanon, as else-
where and out of necessity, takes into consideration re-
source, availability, and culture. In Lebanon, as for other 
places where both clinicians’ recommendation or guid-
ance has been considered alongside auditing or surveying 
of practice, such as the UK (42), there is a disparity be-
tween what clinicians want to happen and frontline clini-
cal practice. 
 
Limitations 
This survey was small and short. Numbers, especially of 
the clinicians, were very small and it is important that two 
of the seven in the sample did not give information. How-
ever, we think the five to be representative of the whole 
group and had considerable experience in the field. We do 
not think that we failed to identify any instances of man-
agement of aggression during the sample period but it is 
possible that the high-quality recording of the use of 
straight jacket and pharmacological treatments (both in the 
drug cards) is systematically better than a description of 
attempts at verbal de-escalation. We may be underestimat-
ing the use of this technique in real practice.  
 
Conclusion 
This small, short, imperfect survey of clinician’s opin-
ion and practice, suggests that in Lebanon, as in other 
countries, what clinicians hope is undertaken in the emer-
gency room is not necessarily what happens. This survey 
also suggested some consistency of clinical approach in 
Lebanon – partly out of necessity as there are limited ap-
proaches to take - but also partly out of clinician choice. 
Experienced clinicians in Lebanon, as for many other 
places, are repeatedly, routinely, using clearly effective 
treatments for managing people who are dangerous. The 
comparative quantified effects of these particular treat-
ment approaches should be underpinned with good evi-
dence from randomized trials.  
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Appendix 
Form 1. Clinicians’ Form 
 
 
Name: ………………………………………………….. 
 
Role: ……………………………………………………….. 
 
Ward: …………………………………………………….. Period of work in mental health:……………. 
QUESTION: How often would you have to manage a person who is acutely aggressive? 
 
QUESTION: When someone is acutely aggressive - what do you think should be used to manage this? 
*Note: Feel free to fill out the intervention steps based on the idea if previous intervention wasn’t successful. 
Intervention #1:………………………………………………………………………………………………………………… 
Intervention #2:………………………………………………………………………………………………………………… 
Intervention #3:………………………………………………………………………………………………………………… 
Intervention #4:………………………………………………………………………………………………………………… 
Intervention #5:………………………………………………………………………………………………………………… 
Intervention #6:………………………………………………………………………………………………………………… 
Intervention #7:………………………………………………………………………………………………………………… 
Intervention #8:………………………………………………………………………………………………………………… 
Intervention #9:………………………………………………………………………………………………………………… 
Would you like to see the results of this survey? Yes  
☐ 
No 
☐ 
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Form 2. Emergency Management Form 
  
 
Unique ID: Ward: 
Suspected cause: 
 
Diagnosis (if applicable):  
Date: Time: Age: Sex: 
Presentation: 
Family -a  Authorities -b  Friends -c  Self -d  Other -e  
Restraints before admission :  
Y/N 
 
possible]If yes, what type of restraint and what duration [if :  
Given treatment before 
admission?  
Y/N  
what was he/she given –If YES  ?  
)directly given by professionals(  
what was he/she given –If YES  ?  
)directly given by family/carer/self(  
Medication after admission for this episode [name, dose, route]:  
Medication # :1  
Medication # : 2  
Medication # :3  
Medication # :4  
Medication # :5  
Medication # :6  
Medication # :7 PTO if necessary  
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